|Bid||0.00 x 50000|
|Ask||0.00 x 194200|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|Beta (5Y Monthly)||0.48|
|PE Ratio (TTM)||14.55|
|Earnings Date||Jul 20, 2021 - Jul 26, 2021|
|Forward Dividend & Yield||0.38 (1.92%)|
|Ex-Dividend Date||Jun 06, 2022|
|1y Target Est||24.39|
Subscribe to Yahoo Finance Plus to view Fair Value for LABB.MX
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend on its common stock of $ 0.381679389 Mexican pesos per share, or a total amount of $ 400,000,000.00 M.N. (four hundred million pesos 00/100 National Curre
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), today announced its results for the first quarter ended March 31, 2022. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS).
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), today announced that it will report its First Quarter 2022 results on Wednesday, April 27, 2022 after the Mexican Market (BMV) close. The company also announced that it will hold a conference call on April 28, 2022 at 11 a.m. ET to discuss its quarterly financial results.